OOIR: Observatory of International Research

Papers

(The median citation count of Expert Review of Proteomics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
The path to anti-vector vaccines: current advances and limitations in proteomics and bioinformatics	26
Proteomic profiling and network biology of colorectal cancer liver metastasis	24
Proteomic insights into the extracellular matrix: a focus on proteoforms and their implications in health and disease	23
How can proteomics help solve the lack of biomarkers to aid in the early diagnosis of motor neuron disease (MND)?	22
24th Human Proteome Organization World Congress; Results from the Early Career Researcher Manuscript Competition announcement	20
The clinical promise of mass spectrometry-based single-cell proteomics: from bedside to bench	18
Plasma proteome profiles of standard-risk and high-risk childhood acute lymphoblastic leukemia	18
Omics and rare diseases: challenges, applications, and future perspectives	16
Oncoproteomic profiling of AML: moving beyond genomics	16
Positional proteomics: is the technology ready to study clinical cohorts?	15
Protein therapeutics in sports drug testing: past, present and future	14
A computational method for the prediction and functional analysis of potential Mycobacterium tuberculosis adhesin-related proteins	13
Mapping the human brain proteome: opportunities, challenges, and clinical potential	13
The method developer’s guide to oligonucleotide design	13
LC-MS/MS: A sensitive and selective analytical technique to detect COVID-19 protein biomarkers in the early disease stage	11
Utilizing databases for astrocyte secretome research	10
Proteomic tools to study phosphorylation of intrinsically disordered proteins	10
Optimization of glycopeptide enrichment techniques for the identification of clinical biomarkers	9
Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detection	9
Unravelling disease complexity: integrative analysis of multi-omic data in clinical research	9
Deciphering mitochondrial metabolic vulnerabilities in ovarian clear cell carcinoma with mass spectrometry-based clinical proteomics	9
Proteomic profiling of cerebrospinal fluid reveals pathophysiology changes and diversity of treatment response in pediatric Streptococcus pneumoniae meningitis	8
Mass spectrometry (MS)-based proteomics and the sulfome: clinical potential	8
Recent advances in mass spectrometry for the detection of doping	7
Proteogenomic profiling of acute myeloid leukemia to identify therapeutic targets	7

Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology	7
A Galaxy of informatics resources for MS-based proteomics	7
Analyzing the glial proteome in Alzheimer’s disease	6
Salivary metabolomics in early detection of oral squamous cell carcinoma – a meta-analysis	6
Advances in the clinical use of metaproteomics	6
Rebellion of the deregulated regulators: What is the clinical relevance of studying intrinsically disordered proteins?	6
T cell population size control by coronin 1 uncovered: from a spot identified by two-dimensional gel electrophoresis to quantitative proteomics	6
The evolution of analytical techniques for multiplex analysis of protein biomarkers	6
Proteomic interrogation of the human olfactory system: the road ahead	6
Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson’s disease	6
How to maximize power for differential expression analysis in discovery omics through experimental design	6
VDAC1: at the crossroads of cancer signalling and metabolism	5
Revisiting the antigen markers of vector-borne parasitic diseases identified by immunomics: identification and application to disease control	5
Unveiling the post translational modification code in Alzheimer’s pathogenesis: crosstalk between phosphorylation and acetylation	5
Recent implementations of data-independent acquisition for cancer biomarker discovery in biological fluids	5
Patient-responsive protein biomarkers for cartilage degeneration and repair identified in the infrapatellar fat pad	5
Tackling reproducibility: lessons for the proteomics community	5
How glycomic studies can impact on prostate cancer	5
Proteomic profiling of oral squamous cell carcinoma tissues reveals altered immune-related proteins: implications for personalized therapy	5
Interaction and regulation of the mitochondrial proteome – in health and disease	5
Integrative analysis of proteomic and MRI data reveals protein associations with brain imaging features in Alzheimer’s disease	5
The use of urine peptidomics to define dietary gluten peptides from patients with celiac disease and the clinical relevance	5
Glycosylation in cancer as a source of biomarkers	5
Extracellular vesicle proteomics in brain solid tumors: future strategy for personalized medicine	5
Evaluation of a ‘plug and play’ nanoflow liquid chromatography system for MS-based proteomic characterization of clinical FFPE specimens	5
Urine proteomics in cardiovascular disease: advances in biomarker discovery and clinical applications	5
MRMAssayDB: a comprehensive integrated resource for targeted proteomics assays	4
How can proteomics be incorporated into the management of atrial fibrillation?	4
Proteomics in the study of female fertility: an update	4
Genetic signatures of suicide attempt behavior: insights and applications	4
The proteomic origin of the genetic code	4
Immobilized metal ion affinity chromatography: waltz of metal ions and biomacromolecules	4
Metabolomics in diabetes mellitus: clinical insight	4
Metabolomics studies in cushing’s syndrome: recent developments and perspectives	4
Mapping the human sperm proteome – novel insights into reproductive research	4
Toward real clinical utility: leveraging comprehensive cancer proteomic datasets for clinical insight	4
Neuroproteomic mapping of kinases and their substrates downstream of acetylcholine: finding and implications	4
AlphaFold and what is next: bridging functional, systems and structural biology	4
Recent progress in quantitative phosphoproteomics	3
Single-cell omics techniques to elucidate cell-to-cell variability in signalling cascades involved in human diseases	3
A proteome-level view of brain tumors for a better understanding of novel diagnosis, prognosis, and therapy	3
Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomics	3
Proteomics applications in next generation induced pluripotent stem cell models	3
Identifying therapeutic strategies for triple-negative breast cancer via phosphoproteomics	3
Proteomic scrutiny of nasal microbiomes: implications for the clinic	3
Glycoproteomic contributions to hepatocellular carcinoma research: a 2023 update	3
Blood plasma proteomic markers of Alzheimer’s disease, current status and application prospects	3
Metabolomics in cardiovascular diseases: from prevention strategies to domain-specific applications	3
An interview with William Cho	3
Spatial Proteomics towards cellular Resolution	3

Protein biomarkers for radiation injury and testing of medical countermeasure efficacy: promises, pitfalls, and future directions	3
Understanding the age-related alterations in the testis-specific proteome	3
Clinical proteomics in inborn errors of metabolism: from biomarker discovery to implementation	3
Proteolytic signaling in cancer	3
How valuable can proteogenomics be in clinical breast cancer research?	3
Oncoproteins E6/E7 of the human papillomavirus types 16 & 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancer	3
Emerging protein sequencing technologies: proteomics without mass spectrometry?	3
Proteomic technologies for profiling cell-membrane/secretome interactions in brain metastatic cancer progression	3
The network map of nesfatin-1-mediated signaling pathway in physiological regulation and pathological conditions	3
Analytical challenges for mapping non-canonical and non-protein ubiquitin/Ubl modifications by mass spectrometry	3